Avicenna Alliance -

Tweet this page
<
2017
2018
2019
2020
>
Registration as it was on 01 Mar 2018
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

75,000€

Financial year: Jan 2017 - Dec 2017

Lobbyists (Full time equivalent)

1 Fte (3)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Avicenna Alliance -

    EU Transparency Register

    551058626331-14 First registered on 14 Mar 2017

    Goals / Remit

    The ASBL aims at the improvement of public health through the promotion of in-silico medicine.

    The activities that enable the achievement of the objectives of the ASBL include: the promotion of policy and legislation at National and European level; engagement with policy-makers through meetings and events; the undertaking of collaborative scientific research projects furthering and supporting the objectives of the ASBL; the promotion of in-silico medicine through social media and traditional media outlets; the development of policy and communication material.

    Main EU files targeted

    eHealth, Clincial Trials Regulation, EMA Regulation, Data Protection Regulation, Medical Devices Regulation, mHealth, EMA Modelling and Simulation policies

    Address

    Head Office
    10 Rue Guimard
    Brussels 1040
    BELGIUM
  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    50%1
    25%2

    Lobbyists (Full time equivalent)

    1

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    Current Secretariat of the Avicenna Alliance is RPP Group

    Person in charge of EU relations

    Mr James Kennedy (EU Policy Consultant)

    Person with legal responsibility

    Mr Thierry Marchal (Secretary General)

  • Categories

    Category

    III - Non-governmental organisations

    Subcategory

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    Member of the European Forum for Good Clinical Practice (EFGCP)

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2017 - Dec 2017

    Lobbying costs for closed financial year

    75,000€

    Other financial info

    Avicenna was established as a legal entity (non-profit) in April 2016 under Belgian law. Prior to this time it operated as an informal platform of industries and researchers.

    Accounting for the Alliance began after its' legal establishment

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    Organisation of logistics of European Parliament event on in silico medicine;

    Contact with the EMA, European Commission and Parliament on the topic of in silico medicine;

    All information can be found at avicenna-alliance.com or contact us directly for any detials

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 08 Feb 2018 Location Brussels
      Subject Computer modelling in healthcare
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
      Other Lobbyists
Download this datacard